Cetera Investment Advisers Acquires 95,353 Shares of iShares U.S. Pharmaceuticals ETF $IHE

Cetera Investment Advisers increased its holdings in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 675.4% during the first quarter, HoldingsChannel reports. The firm owned 109,471 shares of the company’s stock after buying an additional 95,353 shares during the period. Cetera Investment Advisers’ holdings in iShares U.S. Pharmaceuticals ETF were worth $9,489,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Summit Global Investments bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the first quarter worth approximately $583,000. Cassaday & Co Wealth Management LLC purchased a new stake in iShares U.S. Pharmaceuticals ETF in the first quarter worth approximately $85,000. Lifeworks Advisors LLC bought a new stake in iShares U.S. Pharmaceuticals ETF in the 1st quarter worth approximately $301,000. Fifth Third Bancorp raised its stake in iShares U.S. Pharmaceuticals ETF by 462.1% during the 1st quarter. Fifth Third Bancorp now owns 6,560 shares of the company’s stock valued at $569,000 after buying an additional 5,393 shares during the last quarter. Finally, Kestra Advisory Services LLC lifted its holdings in shares of iShares U.S. Pharmaceuticals ETF by 10.0% during the 1st quarter. Kestra Advisory Services LLC now owns 6,303 shares of the company’s stock valued at $546,000 after buying an additional 571 shares during the period.

iShares U.S. Pharmaceuticals ETF Stock Down 1.0%

iShares U.S. Pharmaceuticals ETF stock opened at $102.46 on Friday. The business has a 50-day simple moving average of $96.79 and a two-hundred day simple moving average of $90.94. The company has a market cap of $1.60 billion, a P/E ratio of 17.75 and a beta of 0.49. iShares U.S. Pharmaceuticals ETF has a 52-week low of $64.94 and a 52-week high of $105.02.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.